PROC (Procaps) Rega marang bathi mangsa ngarep
Despite changes in financial personnel due to audit delays, the technical staff at Procaps Group S.A. (PROC) remains stable. Business revenues rely on soft capsule patent licensing and royalties. The projected P/E valuation visualizes these trends, where 0.00 captures the magnitude of this parameter. Final efficiency is based on a combination of proprietary plants and outsourced clinical trials.
Ringkesan rincian data analitis Procaps Group Corp (PROC)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal Procaps Group S.A.|PROC - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Procaps Group S.A.|PROC - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku Procaps Group S.A.|PROC - Kewajiban jangka dawa|Utang jangka cendhak perusahaan Procaps|Likuiditas cepet procapsgroup.com
- rincian asil keuangan lan kelipatan valuasi:
PROC - Penghasilan resik perusahaan|Proyeksi bathi mangsa ngarep Procaps Group S.A.|PROC - Koefisien rega marang bathi|Pangali Forward P/E Procaps Group SA|PROC - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Procaps Group S.A.|PROC - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Procaps|PROC - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan procapsgroup.com|PROC - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Procaps Group S.A.
Pambiji fundamental:PROC Procaps
The cash deficit at Procaps Group S.A. (PROC), driven by restructuring and reporting delays, is amplifying the volatility of market earnings expectations. The business's expected P/E is calculated as the ratio of current market capitalization to projected income, reflecting investors' willingness to pay a premium for future growth, which allows this chart to assess the degree of optimism currently priced in or the risk of asset overvaluation.
Analisis pesaing Procaps Group S.A.
Prakiraan rega marang bathi HLN (Haleon)|KVUE (Kenvue Inc) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Verona Pharma Corp VRNA|Jyong Bio (MENS) - Rasio prakiraan rega marang bathi|LGND: Prakiraan rega marang bathi|amneal.com - Rasio kapitalisasi marang bathi mangsa ngarep|PRGO: Pangali Forward P/E|Alvotech S.A. - Pangali mangsa ngarep rega marang bathi|LQDA (Liquidia Technologies) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Galapagos Corp GLPG|Rega marang bathi mangsa ngarep ANI Pharmaceuticals (ANIP)|MNKD (mannkindcorp.com) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Amphastar Pharmaceuticals, Inc. AMPH|PCRX (Pacira Pharmaceuticals) - Rasio rega marang bathi sing dikarepake|SPRY - Rega marang bathi mangsa ngarep|Pangali mangsa ngarep rega marang bathi TBPH (Theravance Corp)|Aquestive Therapeutics (AQST) - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi scPharmaceuticals (SCPH)|TECX (Tectonic Therapeutic Inc.) - Pangali Forward P/E|Prakiraan rega marang bathi Tonix Pharma (TNXP)|Pangali Forward P/E SXTC|Pangali Forward P/E eupraxiapharma.com (EPRX)|Rega marang bathi mangsa ngarep BioHarvest Sciences BHST|EXOZ (invizyne.com) - Rasio rega marang bathi sing dikarepake|ORMP - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi Entera Bio Ltd. ENTX|HYFT (MindWalk) - Prakiraan rega marang bathi|ABVC BioPharma, Inc - Pangali mangsa ngarep rega marang bathi|CPIX (Cumberland Pharmaceuticals) - Pangali Forward P/E|QNTM - Pangali forward rega marang bathi|Rega marang bathi mangsa ngarep FibroGen (FGEN)|TELO (Telomir Pharmaceuticals Inc) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Rani Therapeutics Holdings, Inc. RANI|Synergy CHC Corp. (SNYR) - Rasio prakiraan rega marang bathi|RLYB: Prakiraan rega marang bathi|LEXX - Pangali Forward P/E|Pulmatrix (PULM) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake PTHL (Pheton Holdings)|Prakiraan rega marang bathi APM|LYRA: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Impact BioMedical Inc (IBO)|Kapitalisasi marang proyeksi bathi tnfpharma.com|cbdMD - Prakiraan rega marang bathi|Kapitalisasi marang proyeksi bathi PainReform Ltd (PRFX)|Auris Medical - Pangali Forward P/E|LIPO - Pangali Forward P/E|OPTN (OptiNose, Inc.) - Prakiraan rega marang bathi|PIRS - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Petros Pharmaceuticals, Inc.|Qilian International Holding Group - Rasio rega marang bathi sing dikarepake|Rega marang bathi mangsa ngarep ACELYRIN, Inc. (SLRN)|TFFP (TFF Pharmaceuticals, Inc) - Pangali mangsa ngarep rega marang bathi
